As per the Center for Disease Control and Prevention (CDC), pneumonia is the primary infectious cause of death in children under five, worldwide. Some of the common symptoms of pneumonia are cough, short breath, fever, chest pain, nausea, and vomiting. Children in underdeveloped or remote communities, especially in South Asian and African countries, are at maximum risk of contracting pneumonia due to the lack of timely interventions, reveals the World Health Organization (WHO). Streptococcus pneumonia is one of the most common causes of pneumonia among children. Others include Haemophilus influenzae type b (Hob) and Pneumocystis jiroveci.
Perceive the Upcoming Market Structure of Pneumonia Diagnostics & Technologies at: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1736
The report furnishes a basic definition of pneumonia, its symptoms, and its various types. Having done so, it outlines the various diagnostics and treatments of the preventable disease. It studies the market for pneumonia diagnostics and technologies by gauging the volume of tests carried out in hospitals, clinics, diagnostic laboratories, and other healthcare settings. The report finds that chest x-ray and CT scan are the preferred diagnostic methods at hospitals, while community healthcare settings usually diagnose on the basis of symptoms.
The research study predicts that the market for pneumonia diagnostics and technologies will expand on account of a burgeoning aging population highly susceptible to pneumonia and the increased occurrence of the malady in children. Besides this, it also lists recent advances in pneumonia diagnostics as a key driving factor. The development of nucleic acid detection tests for major pneumonia pathogens and immunochromatographic pneumococcal urinary antigen tests is one such example.
Region-wise, Europe, North America, and Japan will exhibit robust growth on account of a rapidly increasing geriatric population. The report delves into the market in each of the regions. It also presents information about the key product segments, such as diagnostic kits for pneumonia, sold in the market. Two of them are Directigen S. pneumonia test kit and LCx Chlamydia pneumonia PCR assay kit. Using various analytical tools such as Porter’s Five Forces Analysis and SWOT analysis, the report identifies business expansion opportunities in various regions and product segments. It throws light on market entry barriers and risks to enable both new and existing players build proper strategies.
Some of the key players in the Pneumonia diagnostics & technologies market are Becton Dickinson, Thermo Fisher Scientific, Affymetrix, Bio-Rad, Roche, Abbott Laboratories, and Novartis Diagnostics.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
USA – Canada Toll Free: 866-552-3453